Características
- Relevant information || KBA1
-
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³ AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table. - Expanding functional understanding || KBA1
-
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms. - Enhances decision making || KBA1
-
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow. - New information || KBA1
-
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴ - Step-by-step workflow || KBA1
-
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³
AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table.
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³
AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table.
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms.
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms.
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow.
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow.
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
- Relevant information || KBA1
- Expanding functional understanding || KBA1
- Enhances decision making || KBA1
- New information || KBA1
Veja todos os recursos
- Relevant information || KBA1
-
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³ AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table. - Expanding functional understanding || KBA1
-
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms. - Enhances decision making || KBA1
-
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow. - New information || KBA1
-
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴ - Step-by-step workflow || KBA1
-
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³
AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table.
Relevant information about blood vessel flow
Flow diverters are being increasingly used to treat cerebral aneurysms, but flow diversion procedures remain challenging. Only 76% of all aneurysm flow diversion cases result in thrombosis after 6 month follow-up,¹ which poses a risk to the patient. Several authors have shown that the flow pattern inside aneurysms is considered one of the parameters that can be used to predict rupture and clotting.²,³
AneurysmFlow is the first tool that visualizes and quantifies flow changes in the parent vessel and aneurysm before and after flow diverter deployment. It has also been shown to provide a metric – the Mean Aneurysm Flow Amplitude (MAFA) ratio – that correlates with aneurysm thrombosis.⁴ This information can support real-time decision making while the patient is still on the table.
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms.
Expanding functional understanding
Currently, a combination of digital subtraction angiography (DSA) and three-dimensional rotational angiography (3DRA) is the gold standard for imaging vascular lesions, but it provides limited functional information about flow. AneurysmFlow uses novel algorithms based on the optical flow principle to convert information from a 3DRA acquisition and 2D DSA flow sequences into quantitative flow values. These values are used to visualize and quantify flow dynamics before and after flow diverter deployment in cerebral aneurysms.
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow.
Enhances decision making
AneurysmFlow automatically measures the following parameters within the region of interest defined: time averaged arterial flow, time and spatially averaged projected aneurysm flow, and Mean Aneurysm Flow Amplitude (MAFA) ratio. Users can also view the following information as graphs: time dependent arterial flow and time dependent, spatially averaged projected aneurysm flow.
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴
New information with Mean Aneurysm Flow Amplitude ratio
The Mean Aneurysm Flow Amplitude (MAFA) ratio represents the change in blood flow in the aneurysm after flow diverter deployment. The MAFA ratio is derived by comparing the average projected velocity of the blood flow in the aneurysm before and after flow diverter deployment. This ratio is corrected for average velocity change of the blood flow in the primary feeding vessel to the aneurysm. An initial study compared the compensated MAFA ratio to the results of aneurysm occlusion on follow-up exams. The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P= .035). The authors say, “The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study.” ⁴
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
Step-by-step workflow
AneurysmFlow supports endovascular treatment of saccular cerebral aneurysms of 5 mm and larger with embolization devices, such as flow diverters. Data acquisition can be controlled at the tableside during the normal workflow, while analysis is performed in the control room.
Produtos relacionados
Alternative products
-
Dynamic 3D Roadmap
- Visualização total em 3D fornece orientação em tempo real
- Movimentos sincronizados garantem a precisão
- Reutilização de imagens reduz a exposição à radiação
Veja o produto
-
VasoCT
- Visualização de VasoCT mostra estrutura de vaso além do coágulo
- Imagem de alta resolução do tecido mole aumenta clareza
- Ferramenta não-invasiva é rápida e econômica
- Suporte de tratamento avançado para acidente vascular cerebral isquêmico
Veja o produto
-
FlexVision XL
- Grande visor colorido de LCD lhe dá espaço para trabalhar
- SuperZoom traz imagens mais perto de você
- Visor flexível para a informação certa no momento certo
- Integração total com sistema de Allura Xper para alternar as visualizações facilmente
Veja o produto
-
Allura 3D -RA
- Máxima funcionalidade 3D para excelentes resultados
- Reconstrução em quatro segundos para obter melhores resultados
- Técnica reconstrutiva de Zoom para uma visão mais de perto
- Recursos de compensação para excelente qualidade de imagem
Veja o produto
-
Dynamic 3D Roadmap
Roteiro dinâmico 3D da Philips oferece suporte a intervenções complexas, fornecendo orientação de imagem 3D ao vivo para navegar por estruturas vasculares em qualquer lugar no corpo. Ele sobrepõem imagens de fluoroscopia 2D em tempo real com uma reconstrução 3D da árvore vasos sanguíneos.
Veja o produto
-
VasoCT
VasoCT é uma ferramenta avançada de intervencionista para ajudar neuroradiologists com tratamento de acidente vascular cerebral no laboratório de raios-x intervencionista. Ele ajuda a identificar e avaliar o tamanho e a extensão de uma oclusão no caso de um acidente vascular cerebral isquêmico.
Veja o produto
-
FlexVision XL
Veja pequenos detalhes da complexa anatomia cardiovascular mais facilmente com o grande visor de LCD a cores de 56” do FlexVision XL da Philips para a suíte intervencionista. Isso permite flexibilidade para visualizar várias imagens de diferentes fontes, para intervenções específicas.
Veja o produto
Veja todos os produtos relacionados
